Mersana Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Michael, one of the biotech analysts here, and it's my pleasure to introduce the team from Mersana Therapeutics, starting with Anna Protopapas, CEO; Tim Lowinger, Chief Science and Technology Officer; Arvin Yang, CMO; and Brian DeSchuytner, SVP of Finance and product strategy. So just a quick reminder to everyone, this is a fireside chat today. (Operator Instructions)
But before we get started, I just need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So with that out of the way, Anna and I'll turn it over to you to make some introductory comments, and then we can jump right into the Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
